Alpha DNA Investment Management LLC Buys Shares of 36,860 Aspen Aerogels, Inc. (NYSE:ASPN)

Alpha DNA Investment Management LLC purchased a new position in shares of Aspen Aerogels, Inc. (NYSE:ASPN) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 36,860 shares of the construction company’s stock, valued at approximately $438,000.

A number of other institutional investors have also modified their holdings of ASPN. AlphaQuest LLC lifted its stake in Aspen Aerogels by 54.0% during the 4th quarter. AlphaQuest LLC now owns 11,395 shares of the construction company’s stock worth $135,000 after acquiring an additional 3,998 shares in the last quarter. KLP Kapitalforvaltning AS acquired a new stake in shares of Aspen Aerogels during the fourth quarter worth about $164,000. Journey Strategic Wealth LLC purchased a new position in shares of Aspen Aerogels in the fourth quarter valued at approximately $178,000. Ballentine Partners LLC boosted its stake in shares of Aspen Aerogels by 19.2% in the fourth quarter. Ballentine Partners LLC now owns 15,914 shares of the construction company’s stock valued at $189,000 after purchasing an additional 2,565 shares during the period. Finally, Capula Management Ltd acquired a new position in shares of Aspen Aerogels in the fourth quarter valued at approximately $208,000. 97.64% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities analysts have commented on the stock. Barclays decreased their price target on shares of Aspen Aerogels from $25.00 to $13.00 and set an “overweight” rating for the company in a research report on Wednesday, February 19th. Craig Hallum lowered their target price on Aspen Aerogels from $21.00 to $18.00 and set a “buy” rating for the company in a research note on Friday, February 14th. B. Riley cut their price target on Aspen Aerogels from $35.00 to $22.00 and set a “buy” rating on the stock in a report on Wednesday, February 19th. Canaccord Genuity Group decreased their price objective on Aspen Aerogels from $20.00 to $15.00 and set a “buy” rating for the company in a research note on Friday, February 14th. Finally, TD Cowen upgraded shares of Aspen Aerogels to a “strong-buy” rating in a research note on Tuesday, March 11th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating, eight have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $19.11.

Aspen Aerogels Stock Performance

Shares of ASPN opened at $5.23 on Friday. The company has a quick ratio of 2.48, a current ratio of 2.93 and a debt-to-equity ratio of 0.27. Aspen Aerogels, Inc. has a 52-week low of $4.80 and a 52-week high of $33.15. The stock has a 50 day moving average price of $6.94 and a 200 day moving average price of $12.43. The company has a market capitalization of $429.00 million, a price-to-earnings ratio of 32.66 and a beta of 2.35.

Aspen Aerogels (NYSE:ASPN) last issued its earnings results on Wednesday, February 12th. The construction company reported $0.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a net margin of 2.95% and a return on equity of 7.49%. Research analysts predict that Aspen Aerogels, Inc. will post 0.17 EPS for the current fiscal year.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.